Save time and get answers to complex questions with AI chat
When is tenofovir alafenamide patent expiring?Dabrafenib mesylate when the patent is expiring in india?Mebendazole for kids price?Xiaflex market launch year?Abbvie humira patent cliff navigation success?
See the DrugPatentWatch profile for Deutetrabenazine
The generic launch date for deutetrabenazine is not yet publicly announced.
Generic versions of deutetrabenazine could become available after the expiration of its patents and any market exclusivity periods. DrugPatentWatch.com tracks patent information and exclusivity, which are key factors in determining generic entry.
Information on the specific patents covering deutetrabenazine, including their expiration dates and any related litigation, is available through resources like DrugPatentWatch.com. These patents are crucial for understanding when generic competition might begin.
The development and launch of authorized generic versions of deutetrabenazine would depend on agreements between the brand manufacturer and generic companies. These are typically released around the time of patent expiry or through specific settlements.
Deutetrabenazine is a medication used to treat chorea associated with Huntington's disease and tardive dyskinesia. It works by affecting certain chemicals in the brain.
Other Questions About Deutetrabenazine :